179 related articles for article (PubMed ID: 22314142)
1. Growth hormone and the cardiovascular system.
Palmeiro CR; Anand R; Dardi IK; Balasubramaniyam N; Schwarcz MD; Weiss IA
Cardiol Rev; 2012; 20(4):197-207. PubMed ID: 22314142
[TBL] [Abstract][Full Text] [Related]
2. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
3. Update on early cardiovascular and metabolic risk factors in children and adolescents affected with growth hormone deficiency.
Capalbo D; Esposito A; Di Mase R; Barbieri F; Parenti G; Vajro P; Pignata C; Salerno M
Minerva Endocrinol; 2012 Dec; 37(4):379-89. PubMed ID: 23235193
[TBL] [Abstract][Full Text] [Related]
4. Role of growth hormone in chronic heart failure: therapeutic implications.
Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and the cardiovascular function.
Svensson J; Tivesten A; Isgaard J
Minerva Endocrinol; 2005 Mar; 30(1):1-13. PubMed ID: 15877009
[TBL] [Abstract][Full Text] [Related]
6. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease and risk factors: the role of growth hormone.
Isgaard J
Horm Res; 2004; 62 Suppl 4():31-8. PubMed ID: 15591764
[TBL] [Abstract][Full Text] [Related]
8. Does growth hormone play a role in chronic heart failure?
Volterrani M; Giustina A; Lorusso R; Giordano A
Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
[TBL] [Abstract][Full Text] [Related]
9. Changes in endothelial dysfunction and associated cardiovascular disease morbidity markers in GH-IGF axis pathology.
Graham MR; Evans P; Thomas NE; Davies B; Baker JS
Am J Cardiovasc Drugs; 2009; 9(6):371-81. PubMed ID: 19929035
[TBL] [Abstract][Full Text] [Related]
10. The role of growth hormone in the regulation of body composition in the adult.
Russell-Jones DL; Weissberger AJ
Growth Regul; 1996 Dec; 6(4):247-52. PubMed ID: 8971554
[TBL] [Abstract][Full Text] [Related]
11. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.
Colao A; Di Somma C; Savanelli MC; De Leo M; Lombardi G
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S41-8. PubMed ID: 16690338
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans.
Böger RH
J Endocrinol Invest; 1999; 22(5 Suppl):75-81. PubMed ID: 10442575
[TBL] [Abstract][Full Text] [Related]
16. [Heart disease in acromegaly. Study of 27 patients].
Marín F; Picó AM; Martínez JG; Domínguez JR; Alfayete R; Sogorb F
Med Clin (Barc); 1996 Sep; 107(9):326-30. PubMed ID: 8984234
[TBL] [Abstract][Full Text] [Related]
17. Effects of adult growth hormone deficiency and growth hormone replacement on circadian rhythmicity.
White HD; Ahmad AM; Vora JP
Minerva Endocrinol; 2003 Mar; 28(1):13-25. PubMed ID: 12621360
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of growth hormone treatment: potential risks and benefits.
Colao A
Horm Res; 2004; 62 Suppl 3():42-50. PubMed ID: 15539798
[TBL] [Abstract][Full Text] [Related]
19. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
[TBL] [Abstract][Full Text] [Related]
20. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
